A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)
Incyte Corporation
Incyte Corporation
The Netherlands Cancer Institute
Celldex Therapeutics
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Massachusetts General Hospital
GlaxoSmithKline
Pfizer
FeRx